TRAP1 and breast carcinoma: TRAP1 interference in different cancer cell lines (e.g. colorectal and breast cancers), as well as the use of TRAP1dominant negative mutants, sensitizes cells to multiple cell death inducers, ranging from inhibitors of protein synthesis and degradation to endoplasmic reticulum stress inducers and chemotherapeutics agents [59,62].